Clinical Laboratory CLIA-certified clinical laboratory focused on molecular diagnostic testing for cancer, indicating a need for scalable lab services, B2B partnerships with oncologists and pathologists, and potential for expanded test offerings or contract research services.

FFPE Genomics Specializes in extraction and analysis of genetic information from formalin-fixed paraffin-embedded tumor specimens, suggesting opportunities to cross-sell services to institutions with FFPE archives and to offer archival sample processing for longitudinal studies.

Mid-Sized Growth Revenue in the $10–$25M range with 11–50 employees and modest funding indicates a mid-sized, growth-oriented company that may be open to strategic partnerships, co-development deals, or channel partnerships to accelerate market reach.

Cancer Diagnostic Focus Primary customers are oncologists and pathologists, revealing a pathway for sales through clinical initiatives, reference lab agreements, and companion diagnostics collaborations with pharma companies developing oncology therapies.

Market Fit Compared competitors span from niche labs to large established firms; Response Genetics can differentiate by offering rapid turnaround, specialized FFPE molecular testing, and flexible contract structures to win mid-market cancer testing contracts.